Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $12.9 million.

  • Phibro Animal Health's Depreciation & Amortization (CF) rose 1137.9% to $12.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.7 million, marking a year-over-year increase of 3020.65%. This contributed to the annual value of $45.6 million for FY2025, which is 2605.73% up from last year.
  • Latest data reveals that Phibro Animal Health reported Depreciation & Amortization (CF) of $12.9 million as of Q4 2025, which was up 1137.9% from $12.8 million recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's Depreciation & Amortization (CF) registered a high of $12.9 million during Q4 2025, and its lowest value of $7.8 million during Q2 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $8.7 million (2023), whereas its average is $9.5 million.
  • Per our database at Business Quant, Phibro Animal Health's Depreciation & Amortization (CF) plummeted by 400.1% in 2021 and then skyrocketed by 4249.22% in 2025.
  • Over the past 5 years, Phibro Animal Health's Depreciation & Amortization (CF) (Quarter) stood at $8.0 million in 2021, then grew by 6.22% to $8.5 million in 2022, then increased by 4.84% to $8.9 million in 2023, then increased by 29.9% to $11.6 million in 2024, then increased by 11.38% to $12.9 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $12.9 million for Q4 2025, versus $12.8 million for Q3 2025 and $12.4 million for Q2 2025.